Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Clinical trial NCT05057130 · UNKNOWN
Trial details
- NCT number
- NCT05057130
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2024-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.